L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
Nature communications
View this publicationNature communications
View this publicationEuropean urology
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publicationJournal of clinical oncology : official journal of the American Society of Clinical Oncology
View this publicationNature immunology
View this publicationLung cancer (Amsterdam, Netherlands)
View this publicationScience immunology
View this publicationAmerican journal of translational research
View this publicationHistopathology
View this publicationInternational journal of radiation oncology, biology, physics
View this publication